Cumulative Irritation Test

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 22, 2007

Primary Completion Date

February 19, 2007

Study Completion Date

February 19, 2007

Conditions
Onychomycosis
Interventions
DRUG

AN2690

AN2690 Solution, 2.5%, Daily for up to 21 days

DRUG

AN2690

AN2690 Solution, 7.5%, Daily for up to 21 days

DRUG

AN2690

AN2690 Solution, 5.0%, Daily for up to 21 days

OTHER

AN2690 Solution, Vehicle

AN2690 Solution, Vehicle, Daily for up to 21 days

OTHER

Sodium Lauryl Sulfate, 0.5%

Sodium Lauryl Sulfate, 0.5%, Daily for up to 21 days

Trial Locations (1)

24501

The Education and Research Foundation, Inc., Lynchburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY